Postnatal corticosteroid usage in United Kingdom and Ireland neonatal units.
NICE guidelines
bronchopulmonary dysplasia
dexamethasone
prednisolone
Journal
Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968
Informations de publication
Date de publication:
12 2023
12 2023
Historique:
revised:
05
08
2023
received:
26
06
2023
accepted:
30
08
2023
medline:
9
11
2023
pubmed:
7
9
2023
entrez:
7
9
2023
Statut:
ppublish
Résumé
To perform a survey on postnatal corticosteroids usage in neonatal units in the United Kingdom and Ireland. An 18-item structured questionnaire was created asking for the level of neonatal care and corticosteroid prescribing practices. A consultant neonatologist or senor specialty training registrar/advanced neonatal nurse practitioner was contacted in every neonatal unit in the UK and Ireland between September and December 2022. The response rate to the survey was 96% (203 of 211 units). Postnatal corticosteroids were prescribed in 48% of units: 5% of special care units, 43% of local neonatal units and 100% of neonatal intensive care units. Most units (90%) prescribed dexamethasone, which was prescribed to infants born at gestational ages less than 30 weeks in all those units prescribing postnatal corticosteroids, however, eight units also reported use in infants greater than 30 weeks of gestation. Dexamethasone regimens varied with starting doses from 50 to 500 μg/kg/day. Most tertiary units (97%) prescribed repeated courses of dexamethasone. In all levels of neonatal care, postnatal corticosteroids were prescribed to ventilated infants as well as those receiving non-invasive respiratory support. There is use of postnatal corticosteroids in all levels of neonatal care and much of the practice is not evidence based.
Substances chimiques
Glucocorticoids
0
Dexamethasone
7S5I7G3JQL
Adrenal Cortex Hormones
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2503-2506Informations de copyright
© 2023 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
Références
Siffel C, Kistler KD, Lewis JFM, Sarda SP. Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern Fetal Neonatal Med. 2021;34(11):1721-1731.
Ryan RM, Ahmed Q, Lakshminrusimha S. Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia. Clin Rev Allergy Immunol. 2008;34(2):174-190.
Douglas E, Hodgson KA, Olsen JE, et al. Postnatal corticosteroids and developmental outcomes in extremely preterm or extremely low birth weight infants: the Victorian infant collaborative study 2016-17 cohort. Acta Paediatr. 2023;112(6):1226-1232.
Seok H, Oh JH. Hypertrophic cardiomyopathy in infants from the perspective of cardiomyocyte maturation. Korean Circ J. 2021;51(9):733-751.
Qin G, Lo JW, Marlow N, Calvert SA, Greenough A, Peacock JL. Postnatal dexamethasone, respiratory and neurodevelopmental outcomes at two years in babies born extremely preterm. PloS One. 2017;12(7):e0181176.
Yao S, Uthaya S, Gale C, Modi N, Battersby C. Postnatal corticosteroid use for prevention or treatment of bronchopulmonary dysplasia in England and Wales 2012-2019: a retrospective population cohort study. BMJ Open. 2022;12(11):e063835.
Harris C, Crichton S, Zivanovic S, et al. Effect of dexamethasone exposure on the neonatal unit on the school age lung function of children born very prematurely. PloS One. 2018;13(7):e0200243.
Harris C, Bisquera A, Zivanovic S, et al. Postnatal dexamethasone exposure and lung function in adolescents born very prematurely. PloS One. 2020;15(8):e0237080.
Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial. Pediatrics. 2006;117(1):75-83.
(NICE) NIfHaCE. National Institute for Health and Care Excellence: Guidelines. Specialist Neonatal Respiratory Care for Babies Born Preterm. National Institute for Health and Care Excellence (NICE); 2019.
Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL. Late (>7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2017;10(10):CD001145.
NHS. Implementing the Recommendations of the Neonatal Critical Care Transformation Review. NHS England; 2019.
Health Service Executive (HSE). Model of Care for Neonatal Services in Ireland. HSE; 2015.
Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL. Early (<8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2017;10(10):CD001146.